Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface

Neuronal damage secondary to traumatic brain injury (TBI) is a rapidly evolving condition, which requires therapeutic decisions based on the timely identification of clinical deterioration. Changes in S100B biomarker levels are associated with TBI severity and patient outcome. The S100B quantificati...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez, Alexander, Burgos-Flórez, Francisco, Posada, José D., Cervera, Eliana, Zucolotto, Valtencir, Sanjuán, Homero, Sanjuán, Marco, Villalba, Pedro J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001999/
https://www.ncbi.nlm.nih.gov/pubmed/33801798
http://dx.doi.org/10.3390/s21061929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001999/
https://www.ncbi.nlm.nih.gov/pubmed/33801798
http://dx.doi.org/10.3390/s21061929

Ejemplares similares